Synova Healthcare Announces Launch of Fem-V(TM) to Women's Health Care Physicians
Posted on: Thursday, 27 April 2006, 09:01 CDT
MEDIA, Pa., April 27 /PRNewswire-FirstCall/ -- Synova Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. (BULLETIN BOARD: SNVH) , announced today that the Fem-V(TM) Vaginal Infection Test will be introduced first to those women's health care physicians attending the 54th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. The A.C.O.G. medical conference will take place May 6-10 in Washington, D.C., where approximately 5,000 professional attendees are anticipated to attend.
Fem-V(TM) is an over-the-counter, non-invasive diagnostic test developed to assist women in the diagnosis of vaginal infections, directing them toward the appropriate treatment for the condition. For the millions of American women who experience vaginal infections annually, this novel, easy-to-use, at- home test found within a unique pantiliner design, will help determine if an over-the-counter treatment may be considered for symptoms, or if the user should seek treatment from a health care professional.
"We are pleased to be introducing Fem-V(TM) to the various health care professionals attending A.C.O.G. this year," stated Ms. Patty Bowman, Vice President of Marketing at Synova. "Evidence clearly suggests that vaginal infections can lead to further complications if left untreated, or if treated with inappropriate medicines. Therefore, we believe the health care community will be supportive of Fem-V(TM) and our simple message of 'test, then treat' when it comes to the symptoms of vaginal infections."
Synova also announced today the successful agencies who will be partnering with the Company throughout the launch of Fem-V(TM). The agencies engaged to support the marketing and public relations for Fem-V(TM) include Pavone, UnREAL Marketing and Toplin & Associates. Pavone will develop the core Fem-V(TM) marketing communications and advertising campaign. UnREAL Marketing will provide online services related to Fem-V(TM) that include web site design, natural optimization, and search engine marketing. Toplin & Associates will be responsible for the public relations effort supporting the brand.
About Synova Healthcare Group, Inc.:
Synova Healthcare Group, Inc., (SNVH), presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company's products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
About Pavone:
With offices in Philadelphia and Harrisburg, Pavone (http://www.pavone.net/), a thinkbank, provides an array of marketing, advertising, and public relations services to clients across several industries. Pavone's healthcare and pharmaceutical experience includes work with Ester-C, Glide dental floss, several healthcare systems, and GI Supply's SPOT endoscopic marker.
About UnREAL Marketing:
Based in Narberth, Pennsylvania, UnREAL is an online marketing firm dedicated to the profitable growth of its clients. Since the inception of search marketing in the nineties, the firm has delivered innovative marketing solutions through advanced technology, strategic creative insight, and comprehensive online marketing services that produce results. UnREAL's creative and web development team has built powerful, user-friendly and aesthetically pleasing web sites that simply attract and convert visitors into customers. In addition to working in the health care and life science industries, UnREAL has also serviced a diverse range of regional and industry leading world-class clients. (http://www.unrealmarketing.com/)
About Toplin & Associates:
Over the past 24 years, Toplin & Associates, Inc., a full-service marketing, public relations and advertising agency, has represented more than 100 healthcare and health-related products, services, practitioners and institutions. Toplin has launched health care products and procedures with direct-to-consumer initiatives, public information programs and promotions in more than 60 markets across the country. Among the agency's successes have been the launch of LASIK, the country's first corrective eye surgery laser and support throughout the FDA approval process, as well as national publicity for the world's first snoring correction laser and cosmetic surgery laser procedures. (http://www.toplin.com/)
~~~~~~~~~~~~~~~~~~~~~~~~~~~~
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates,""believes,""estimates,""expects,""plans,""intends,""potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2005, as filed with the Securities and Exchange Commission on April 17, 2006, as well as in other periodic reports and filings with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc. Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com/ Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.
CONTACT: Mr. Robert Edwards, CFO, Synova Healthcare Group, Inc.,+1-610-565-7080, Fax: +1-610-565-7081, info@synovahealthcare.com
Web site: http://www.synovahealthcare.com/
Source: PRNewswire-FirstCall
Related Articles
- National Health Partners Releases Statement Regarding the Current Financial Turmoil
- USC Care Medical Group Inc. Signs Multi-Suite Lawson Software Contract
- LifeScience Alley Joins Buyers Health Care Action Group Summit
- Buyers Health Care Action Group and Health and Performance Improvement Advisors, LLC Advance Employer Imperative
- Anadys Pharmaceuticals Invites Investors to Listen to Webcast of Anti-Infectives Panel Discussion at RBC Capital Markets Healthcare Conference
- Cytokinetics to Present at the 2006 RBC Capital Markets Healthcare Conference
- Former President Bill Clinton to Speak at the Perspectives in Healthcare Forum Hosted By Huron Consulting Group and the Kellogg School of Management at Northwestern University
- Health Care Solutions Group Convenes at First Summit
- Leading Healthcare Executives, Private Equity Funds and Dealmakers Convene at 3rd Annual Mid-Market Healthcare M&A Conference in Nashville, TN.
- Research and Markets: Worldwide Prescription Drug Market for Women's Health Forecast to Grow to $11.6 Billion in 2009
 |
 |
User Comments (0)
RSS Feeds